Vivid Seats director granted 19,488 RSUs

Masino Julie D. reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 06/11/2026 - 04:15 PM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Masino Julie D. reported acquisition or exercise transactions in this Form 4 filing.

Vivid Seats Inc. director Julie D. Masino received a grant of 19,488 Restricted Stock Units on June 9, 2026. Each RSU represents a contingent right to receive one share of Class A common stock. The RSUs vest in full on the earlier of June 9, 2027 or one day before the 2027 Annual Meeting of Stockholders, and she now holds 19,488 RSUs directly.

Insider Trade Summary

Grant/Award: 19,488 shares

Grant/Award 1 txn

Insider Masino Julie D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	19,488	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 19,488 contracts (Direct)

Holdings Before and After: Restricted Stock Units, 0 to 19,488 contracts (Direct)

Footnotes (2)

F1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2. The RSUs vest in full on the earlier of (i) June 9, 2027 and (ii) one day prior to the Company's 2027 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

Key Figures

RSUs granted: 19,488 RSUs RSU-to-share ratio: 1 RSU : 1 share Vesting date: June 9, 2027 +2 more

5 metrics

RSUs granted 19,488 RSUs Grant to director Julie D. Masino on June 9, 2026

RSU-to-share ratio 1 RSU : 1 share Each RSU equals one share of Class A common stock

Vesting date June 9, 2027 Vests on earlier of this date or one day before 2027 annual meeting

Holdings after grant 19,488 RSUs Total RSUs directly held following this transaction

Exercise price $0.00 per unit RSU grant carries no exercise price per the filing

Key Terms

Restricted Stock Units, Class A common stock, vest in full, Annual Meeting of Stockholders

4 terms

Restricted Stock Units financial

"Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A common stock financial

"receive one share of Class A common stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

vest in full financial

"The RSUs vest in full on the earlier of (i) June 9, 2027"

Annual Meeting of Stockholders financial

"one day prior to the Company's 2027 Annual Meeting of Stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Vivid Seats (SEAT) disclose for Julie D. Masino?

Vivid Seats reported that director Julie D. Masino received 19,488 Restricted Stock Units as a grant. These RSUs were awarded on June 9, 2026 and represent a contingent right to receive Class A common shares as they vest in the future.

How many Restricted Stock Units did Julie D. Masino receive at Vivid Seats (SEAT)?

Julie D. Masino received a grant of 19,488 Restricted Stock Units from Vivid Seats. Each RSU corresponds to one share of Class A common stock, giving her compensation-linked equity exposure tied directly to the company’s future stock performance once the units vest.

When do Julie D. Masino’s Vivid Seats (SEAT) RSUs vest?

The RSUs awarded to Julie D. Masino vest in full on the earlier of June 9, 2027 or one day prior to Vivid Seats’ 2027 Annual Meeting of Stockholders. Vesting must occur before she actually receives the underlying Class A common shares.

What does each Restricted Stock Unit represent for Vivid Seats (SEAT) insiders?

Each Restricted Stock Unit granted to Julie D. Masino represents a contingent right to receive one share of Vivid Seats Class A common stock. The RSUs convert into actual shares only if the vesting conditions are satisfied according to the grant’s specified schedule and terms.

Does the Vivid Seats (SEAT) RSU grant to Julie D. Masino have an expiration date?

The filing states that Julie D. Masino’s RSUs do not have an expiration date. Instead, they are governed by a vesting condition, becoming shares of Class A common stock once the earlier of the stated vesting dates is reached under the grant terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Masino Julie D.

(Last)

(First)

(Middle)

C/O VIVID SEATS INC.

24 E. WASHINGTON ST., STE. 900

(Street)

CHICAGO

ILLINOIS

60602

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vivid Seats Inc. [ SEAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	06/09/2026		A		19,488		⁽²⁾	⁽²⁾	Class A Common Stock	19,488	$0	19,488	D

Explanation of Responses:

1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock.

2. The RSUs vest in full on the earlier of (i) June 9, 2027 and (ii) one day prior to the Company's 2027 Annual Meeting of Stockholders. The RSUs do not have an expiration date.

	/s/ Lawrence Fey, Attorney-in-Fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR